Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39652675

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2025 May 8
First author
Dimopoulos MA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Aug 7;393(6):616-617. doi: 10.1056/NEJMc2507790.
    note
    Source null
    related pmid
    40768725
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Aug 7;393(6):617. doi: 10.1056/NEJMc2507790.
    note
    Source null
    related pmid
    40768726
    relationship
    Comment in
  3. citation
    N Engl J Med. 2026 Apr 9;394(14):1456. doi: 10.1056/NEJMx250006.
    note
    Source null
    related pmid
    41950488
    relationship
    Erratum in

Authors and identifiers

  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Voorhees PM
    type
    Author
  3. name
    Schjesvold F
    type
    Author
  4. name
    Cohen YC
    type
    Author
  5. name
    Hungria V
    type
    Author
  6. name
    Sandhu I
    type
    Author
  7. name
    Lindsay J
    type
    Author
  8. name
    Baker RI
    type
    Author
  9. name
    Suzuki K
    type
    Author
  10. name
    Kosugi H
    type
    Author
  11. name
    Levin MD
    type
    Author
  12. name
    Beksac M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Voorhees PM
    type
    Author
  3. name
    Schjesvold F
    type
    Author
  4. name
    Cohen YC
    type
    Author
  5. name
    Hungria V
    type
    Author
  6. name
    Sandhu I
    type
    Author
  7. name
    Lindsay J
    type
    Author
  8. name
    Baker RI
    type
    Author
  9. name
    Suzuki K
    type
    Author
  10. name
    Kosugi H
    type
    Author
  11. name
    Levin MD
    type
    Author
  12. name
    Beksac M
    type
    Author
bibliography ids
  1. nci-bib-8b2ee9b37defde0075008e47
book metadata
content sha256
d72c9fbe4928c7962a25bd3236c2308f63cf731334519f8850bc9ebc7860cda0
document type
citation
dois
  1. 10.1056/NEJMoa2409029
electronic publication date
display
2024 Dec 9
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:39652675
immutable id
pubmed:39652675@d72c9fbe4928c7962a25bd3236c2308f63cf731334519f8850bc9ebc7860cda0
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1777-1788
volume
392
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Aug 7;393(6):616-617. doi: 10.1056/NEJMc2507790.
    note
    Source null
    related pmid
    40768725
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Aug 7;393(6):617. doi: 10.1056/NEJMc2507790.
    note
    Source null
    related pmid
    40768726
    relationship
    Comment in
  3. citation
    N Engl J Med. 2026 Apr 9;394(14):1456. doi: 10.1056/NEJMx250006.
    note
    Source null
    related pmid
    41950488
    relationship
    Erratum in
outcomes validated
false
pmid
39652675
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
2a7b380a1300637f13758e736998677926bf495598703ccd90abea538493ce48
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 May 8
precision
day
year
2025
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
  5. Comparative Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39652675/
title
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Preserved source evidence · Not medical advice